Processa Pharmaceuticals Valuation
| PCSA Stock | USD 0.98 0.12 13.95% |
Today, the company appears to be undervalued. Processa Pharmaceuticals holds a recent Real Value of $1.46 per share. The prevailing price of the company is $0.98. Our model determines the value of Processa Pharmaceuticals from analyzing the company fundamentals such as Return On Equity of -2.12, shares owned by institutions of 1.48 %, and Shares Outstanding of 3.27 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Processa Pharmaceuticals' valuation include:
Price Book 0.7552 | Enterprise Value 400.5 K | Enterprise Value Ebitda (0.14) |
Undervalued
Today
Please note that Processa Pharmaceuticals' price fluctuation is dangerous at this time. Calculation of the real value of Processa Pharmaceuticals is based on 3 months time horizon. Increasing Processa Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Processa Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Processa Stock. However, Processa Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.98 | Real 1.46 | Target 3.0 | Hype 0.97 | Naive 0.9 |
The real value of Processa Stock, also known as its intrinsic value, is the underlying worth of Processa Pharmaceuticals Company, which is reflected in its stock price. It is based on Processa Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Processa Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Processa Pharmaceuticals helps investors to forecast how Processa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Processa Pharmaceuticals more accurately as focusing exclusively on Processa Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Processa Pharmaceuticals' intrinsic value based on its ongoing forecasts of Processa Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Processa Pharmaceuticals' closest peers. If more than one evaluation category is relevant for Processa Pharmaceuticals we suggest using both methods to arrive at a better estimate.
Processa Pharmaceuticals Cash |
|
Processa Valuation Trend
Comparing Processa Pharmaceuticals' enterprise value against its market capitalization is a good way to estimate the value of Processa Pharmaceuticals uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Processa Pharmaceuticals Total Value Analysis
Processa Pharmaceuticals is at this time projected to have valuation of 400.45 K with market capitalization of 3.2 M, debt of 150.55 K, and cash on hands of 12.06 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Processa Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
400.45 K | 3.2 M | 150.55 K | 12.06 M |
Processa Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Processa is to check how much profit was generated for every dollar of assets it reports. Processa Pharmaceuticals holds a negative application of assets of -1.13 pct., losing $0.0113 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Processa Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Processa Pharmaceuticals Ownership Allocation
Processa Pharmaceuticals holds 8.74 pct. of its outstanding shares held by insiders and 1.48 pct. owned by third-party entities.Processa Pharmaceuticals Profitability Analysis
Net Loss for the year was (11.12 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Processa Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Processa Pharmaceuticals and how it compares across the competition.
About Processa Pharmaceuticals Valuation
The stock valuation mechanism determines Processa Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Processa Pharmaceuticals. We calculate exposure to Processa Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Processa Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | (222.00) | (233.10) | |
| Pretax Profit Margin | (77.55) | (73.67) | |
| Operating Profit Margin | 12.87 | 13.52 | |
| Net Loss | (77.28) | (73.41) | |
| Gross Profit Margin | 0.65 | 0.68 |
Processa Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.3 M |
Processa Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Processa Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Processa we look at many different elements of the entity such as Processa's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Processa Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Processa Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Processa Pharmaceuticals' worth.Complementary Tools for Processa Stock analysis
When running Processa Pharmaceuticals' price analysis, check to measure Processa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Processa Pharmaceuticals is operating at the current time. Most of Processa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Processa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Processa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Processa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |